Drug: FLUDARABINE Injury: Acute graft versus host disease Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
64815423 | FLUDARABINE | Acute graft versus host disease | BRISTOL MYERS SQUIBB | 53.00 YR | M | 0 | 20160812 | PT |
125683981 | FLUDARABINE | Acute graft versus host disease | NOVARTIS | 38.00 YR | F | 0 | 20160718 | KR |
125683992 | FLUDARABINE | Acute graft versus host disease | SANDOZ | 51.00 YR | M | 0 | 20160725 | KR |
125684011 | FLUDARABINE | Acute graft versus host disease | NOVARTIS | 20.00 YR | M | 0 | 20160718 | KR |
126927461 | FLUDARABINE | Acute graft versus host disease | ACCORD | 7.00 YR | M | 0 | 20160829 | IN |
126927591 | FLUDARABINE | Acute graft versus host disease | ACCORD | 5.00 YR | M | 0 | 20160829 | IN |
127583571 | FLUDARABINE | Acute graft versus host disease | ASPEN | 54.00 YR | M | 0 | 20160919 | FR |
Total Records: 7 Number of Pages: 1